BIOCHEMICAL MARKERS OF ENDOTHELIAL DYSFUNCTION IN CORONARY HEART DISEASE PATIENTS

被引：0
|
作者：
Romanova, Valentyna [1 ]
机构：
[1] Natl Pirogov Mem Med Univ, Vinnytsya, Ukraine
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2018年 / 32卷
关键词：
D O I：
10.1016/j.atherosclerosissup.2018.04.356
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P3.097
引用
收藏
页码：115 / 116
页数：2
相关论文
共 50 条
  • [31] Increasing Endothelial Dysfunction Markers Level are Associated with the Incidence of Heart Failure in Patients with Acute Coronary Syndrome
    Kosaki, Ryota
    Minoura, Yoshino
    Tsukamoto, Shigeto
    Nomura, Kosuke
    Sakai, Koshiro
    Kondo, Seita
    Tsujita, Hiroaki
    Hamazaki, Yuji
    Kobayashi, Youichi
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S173 - S173
  • [32] Endothelial function in patients with cardiovascular diseases. Part II: endothelial dysfunction in patients with hypertension and coronary heart disease
    Poreba, Rafal
    Derkacz, Arkadiusz
    Poreba, Malgorzata
    Andrzejak, Ryszard
    ARTERIAL HYPERTENSION, 2006, 10 (02): : 147 - 152
  • [33] Endothelial dysfunction and inflammation in patients with coronary artery disease
    Lopez-Jaramillo, P
    Cubillos, LA
    Casas, JP
    Silva, F
    Oubina, MP
    Cachofeiro, V
    Lahera, V
    JOURNAL OF HYPERTENSION, 2004, 22 : S250 - S250
  • [34] Endothelial dysfunction and coronary artery disease in patients with COPD
    MacLeod, Mairi
    Knott, Kristopher
    Lopez, Ralph
    Bartlett-Pestell, Sam
    Braddy-Green, Aaron
    Khamis, Ramzi Y.
    Barnes, Peter J.
    Collins, Peter
    Nicol, Ed D.
    Wedzicha, Jadwiga A.
    Paschalaki, Koralia
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [35] Biochemical coronary heart disease risk markers in young black women
    Davis, EE
    Huffman, FG
    FASEB JOURNAL, 2005, 19 (05): : A1037 - A1037
  • [36] Measures of chronic heart failure as the markers of cognitive dysfunction in patients with coronary heart disease complicated by circulatory failure
    Akimova, Natalya S.
    Bugaeva, Oksana, V
    Konshina, Larisa E.
    Shvarts, Yury G.
    COR ET VASA, 2021, 63 (01) : 20 - 24
  • [37] Functional interplay between endothelial dysfunction and platelet activation in patients with stable coronary heart disease
    Robinson, SD
    Harding, SA
    Cummins, P
    Sarma, J
    Davidson, I
    Fox, KA
    Boon, NA
    Newby, DE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 450A - 450A
  • [38] Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease
    Robinson, SD
    Ludlam, CA
    Boon, NA
    Newby, DE
    HEART, 2006, 92 (02) : 170 - 176
  • [39] HYPERRESISTINEMIA IS AN INDEPENDENT RISK FACTOR FOR ENDOTHELIAL DYSFUNCTION AND ANGIOGRAPHIC EXTENT IN PATIENTS WITH CORONARY HEART DISEASE
    Huang, X-S
    Pu, X-Q
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [40] Impact of Hypertriglyceridemia on Endothelial Dysfunction During Statin ± Ezetimibe Therapy in Patients With Coronary Heart Disease
    Yunoki, Kei
    Nakamura, Kazufumi
    Miyoshi, Toru
    Enko, Kenki
    Kubo, Motoki
    Murakami, Masato
    Hata, Yoshiki
    Kohno, Kunihisa
    Morita, Hiroshi
    Kusano, Kengo F.
    Ito, Hiroshi
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (03): : 333 - 339
12345